Much of its tailwinds are attributed to the US President Donald Trump finally signing "an executive order to classify ...

Cannabis stocks, as measured by the Global Cannabis Stock Index, were quite volatile in 2024 and then in 2025 as well. While ...

TLRY remains a Hold, despite the double digits international growth prospects and the potential synergy from its vertically ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Samuel O'Brient Every time Samuel publishes a story, you’ll get an alert straight to your inbox ...

Cannabis stocks surged Friday in the wake of reports that President Trump is preparing to reclassify marijuana under federal law — a long-awaited shift that investors say could loosen restrictions and ...

Marijuana stocks spun higher in market trade Friday, rallying on reports President Donald Trump aims to loosen federal restrictions on marijuana. Plans call for cutting oversight of marijuana products ...

Tilray Brands' stock performance hinges on the outlook for marijuana reform in the U.S. President Trump is considering rescheduling marijuana, which has investors bullish on Tilray of late. The ...

Donald Trump signed an executive order on Dec. 18 to fast-track the Food and Drug Administration's review to reclassify cannabis as a Schedule III substance under the Controlled Substances Act. Pot ...

Cannabis stocks are marching higher on reports that U.S. Medicare is considering covering CBD treatments for some patients, providing a potential new revenue stream for the struggling industry.